Titre : Prise de décision

Prise de décision : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Prise de décision : Questions médicales les plus fréquentes", "headline": "Prise de décision : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Prise de décision : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-18", "dateModified": "2025-03-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Prise de décision" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Pensée (activité mentale)", "url": "https://questionsmedicales.fr/mesh/D013850", "about": { "@type": "MedicalCondition", "name": "Pensée (activité mentale)", "code": { "@type": "MedicalCode", "code": "D013850", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.785" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Apprentissage par évitement", "alternateName": "Avoidance Learning", "url": "https://questionsmedicales.fr/mesh/D001362", "about": { "@type": "MedicalCondition", "name": "Apprentissage par évitement", "code": { "@type": "MedicalCode", "code": "D001362", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.785.373.173" } } }, { "@type": "MedicalWebPage", "name": "Comportement de choix", "alternateName": "Choice Behavior", "url": "https://questionsmedicales.fr/mesh/D002755", "about": { "@type": "MedicalCondition", "name": "Comportement de choix", "code": { "@type": "MedicalCode", "code": "D002755", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.785.373.346" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Choix de carrière", "alternateName": "Career Choice", "url": "https://questionsmedicales.fr/mesh/D002321", "about": { "@type": "MedicalCondition", "name": "Choix de carrière", "code": { "@type": "MedicalCode", "code": "D002321", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.785.373.346.400" } } }, { "@type": "MedicalWebPage", "name": "Dévalorisation de la gratification différée", "alternateName": "Delay Discounting", "url": "https://questionsmedicales.fr/mesh/D065786", "about": { "@type": "MedicalCondition", "name": "Dévalorisation de la gratification différée", "code": { "@type": "MedicalCode", "code": "D065786", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.785.373.346.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Consensus", "alternateName": "Consensus", "url": "https://questionsmedicales.fr/mesh/D032921", "about": { "@type": "MedicalCondition", "name": "Consensus", "code": { "@type": "MedicalCode", "code": "D032921", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.785.373.433" } } }, { "@type": "MedicalWebPage", "name": "Désaccords et litiges", "alternateName": "Dissent and Disputes", "url": "https://questionsmedicales.fr/mesh/D034462", "about": { "@type": "MedicalCondition", "name": "Désaccords et litiges", "code": { "@type": "MedicalCode", "code": "D034462", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.785.373.476" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Refus de participer", "alternateName": "Refusal to Participate", "url": "https://questionsmedicales.fr/mesh/D045808", "about": { "@type": "MedicalCondition", "name": "Refus de participer", "code": { "@type": "MedicalCode", "code": "D045808", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F02.463.785.373.476.850" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Prise de décision", "alternateName": "Decision Making", "code": { "@type": "MedicalCode", "code": "D003657", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Giuseppe Forte", "url": "https://questionsmedicales.fr/author/Giuseppe%20Forte", "affiliation": { "@type": "Organization", "name": "Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy." } }, { "@type": "Person", "name": "Matteo Morelli", "url": "https://questionsmedicales.fr/author/Matteo%20Morelli", "affiliation": { "@type": "Organization", "name": "Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy." } }, { "@type": "Person", "name": "Maria Casagrande", "url": "https://questionsmedicales.fr/author/Maria%20Casagrande", "affiliation": { "@type": "Organization", "name": "Department of Dynamic, Clinical Psychology and Health Studies, Sapienza University of Rome, 00185 Rome, Italy." } }, { "@type": "Person", "name": "Jürgen Kasper", "url": "https://questionsmedicales.fr/author/J%C3%BCrgen%20Kasper", "affiliation": { "@type": "Organization", "name": "Department of Nursing and Health Promotion, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway." } }, { "@type": "Person", "name": "Juliana Yin Li Kan", "url": "https://questionsmedicales.fr/author/Juliana%20Yin%20Li%20Kan", "affiliation": { "@type": "Organization", "name": "Singapore General Hospital Internal Medicine, Singapore. juliana.kan.y.l@singhealth.com.sg." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/35916049", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3346/jkms.2022.37.e241" } }, { "@type": "ScholarlyArticle", "name": "[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].", "datePublished": "2022-10-07", "url": "https://questionsmedicales.fr/article/36205744", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00120-022-01945-x" } }, { "@type": "ScholarlyArticle", "name": "[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36427493", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1902-6326" } }, { "@type": "ScholarlyArticle", "name": "Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.", "datePublished": "2023-06-14", "url": "https://questionsmedicales.fr/article/37316688", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10995-023-03732-2" } }, { "@type": "ScholarlyArticle", "name": "Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/37543936", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.34172/aim.2023.22" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes psychologiques", "item": "https://questionsmedicales.fr/mesh/D011579" }, { "@type": "ListItem", "position": 3, "name": "Processus mentaux", "item": "https://questionsmedicales.fr/mesh/D008606" }, { "@type": "ListItem", "position": 4, "name": "Pensée (activité mentale)", "item": "https://questionsmedicales.fr/mesh/D013850" }, { "@type": "ListItem", "position": 5, "name": "Prise de décision", "item": "https://questionsmedicales.fr/mesh/D003657" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Prise de décision - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Prise de décision", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Prise de décision", "description": "Comment évaluer un diagnostic médical ?\nQuels outils aident à la prise de décision diagnostique ?\nQuelle est l'importance des tests de laboratoire ?\nComment gérer l'incertitude dans le diagnostic ?\nQuel rôle joue l'expérience du médecin dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D003657?mesh_terms=Pilot+Projects&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Prise de décision", "description": "Comment prioriser les symptômes du patient ?\nQuels symptômes nécessitent une attention immédiate ?\nComment les symptômes influencent-ils la décision thérapeutique ?\nQuelle est l'importance de l'historique des symptômes ?\nComment évaluer l'évolution des symptômes ?", "url": "https://questionsmedicales.fr/mesh/D003657?mesh_terms=Pilot+Projects&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Prise de décision", "description": "Comment intégrer la prévention dans la prise de décision ?\nQuels sont les principaux types de prévention ?\nComment évaluer l'adhésion aux mesures préventives ?\nQuel rôle joue l'éducation du patient en prévention ?\nComment évaluer l'impact des interventions préventives ?", "url": "https://questionsmedicales.fr/mesh/D003657?mesh_terms=Pilot+Projects&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Prise de décision", "description": "Comment choisir un traitement approprié ?\nQuel rôle joue le consentement éclairé ?\nComment évaluer l'efficacité d'un traitement ?\nQuels facteurs influencent le choix du traitement ?\nComment gérer les échecs de traitement ?", "url": "https://questionsmedicales.fr/mesh/D003657?mesh_terms=Pilot+Projects&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Prise de décision", "description": "Comment anticiper les complications d'un traitement ?\nQuels sont les signes de complications à surveiller ?\nComment gérer les complications post-traitement ?\nQuel est l'impact des complications sur la prise de décision ?\nComment évaluer le risque de complications ?", "url": "https://questionsmedicales.fr/mesh/D003657?mesh_terms=Pilot+Projects&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Prise de décision", "description": "Comment identifier les facteurs de risque d'une maladie ?\nQuel rôle jouent les facteurs de risque dans la prévention ?\nComment évaluer l'impact des facteurs de risque ?\nQuels sont les facteurs de risque modifiables ?\nComment intégrer les facteurs de risque dans la prise de décision ?", "url": "https://questionsmedicales.fr/mesh/D003657?mesh_terms=Pilot+Projects&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer un diagnostic médical ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des antécédents médicaux, examens physiques et tests diagnostiques." } }, { "@type": "Question", "name": "Quels outils aident à la prise de décision diagnostique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les algorithmes, les guides cliniques et les outils d'aide à la décision." } }, { "@type": "Question", "name": "Quelle est l'importance des tests de laboratoire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Ils fournissent des données objectives pour confirmer ou infirmer un diagnostic." } }, { "@type": "Question", "name": "Comment gérer l'incertitude dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Considérer des diagnostics différentiels et impliquer le patient dans la décision." } }, { "@type": "Question", "name": "Quel rôle joue l'expérience du médecin dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'expérience aide à reconnaître des schémas et à évaluer rapidement les options." } }, { "@type": "Question", "name": "Comment prioriser les symptômes du patient ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer la gravité, la durée et l'impact sur la qualité de vie du patient." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une attention immédiate ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes graves comme la douleur thoracique ou la difficulté respiratoire." } }, { "@type": "Question", "name": "Comment les symptômes influencent-ils la décision thérapeutique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils orientent le choix du traitement en fonction de leur nature et de leur gravité." } }, { "@type": "Question", "name": "Quelle est l'importance de l'historique des symptômes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il aide à établir un diagnostic précis et à choisir le traitement approprié." } }, { "@type": "Question", "name": "Comment évaluer l'évolution des symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les changements dans le temps et leur réponse aux traitements administrés." } }, { "@type": "Question", "name": "Comment intégrer la prévention dans la prise de décision ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer les risques et recommander des mesures préventives adaptées au patient." } }, { "@type": "Question", "name": "Quels sont les principaux types de prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Prévention primaire, secondaire et tertiaire, chacune ciblant différents stades." } }, { "@type": "Question", "name": "Comment évaluer l'adhésion aux mesures préventives ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des questionnaires et des suivis réguliers pour mesurer l'engagement." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation du patient en prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elle augmente la sensibilisation et encourage des comportements sains." } }, { "@type": "Question", "name": "Comment évaluer l'impact des interventions préventives ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Analyser les données de santé et les résultats cliniques sur le long terme." } }, { "@type": "Question", "name": "Comment choisir un traitement approprié ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer l'efficacité, les effets secondaires et les préférences du patient." } }, { "@type": "Question", "name": "Quel rôle joue le consentement éclairé ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il assure que le patient comprend les options et les risques avant de décider." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Surveiller les résultats cliniques et les effets secondaires au fil du temps." } }, { "@type": "Question", "name": "Quels facteurs influencent le choix du traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les comorbidités, les préférences du patient et les lignes directrices cliniques." } }, { "@type": "Question", "name": "Comment gérer les échecs de traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Réévaluer le diagnostic et envisager des alternatives thérapeutiques." } }, { "@type": "Question", "name": "Comment anticiper les complications d'un traitement ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer les risques associés et surveiller les signes précoces de complications." } }, { "@type": "Question", "name": "Quels sont les signes de complications à surveiller ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes inhabituels, l'aggravation de l'état et les effets secondaires." } }, { "@type": "Question", "name": "Comment gérer les complications post-traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Établir un plan de suivi et ajuster le traitement en fonction des complications." } }, { "@type": "Question", "name": "Quel est l'impact des complications sur la prise de décision ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent nécessiter des ajustements dans le traitement et la gestion du patient." } }, { "@type": "Question", "name": "Comment évaluer le risque de complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des outils d'évaluation des risques et des antécédents médicaux." } }, { "@type": "Question", "name": "Comment identifier les facteurs de risque d'une maladie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Analyser les antécédents familiaux, le mode de vie et les conditions médicales." } }, { "@type": "Question", "name": "Quel rôle jouent les facteurs de risque dans la prévention ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Ils aident à cibler les interventions préventives pour les populations à risque." } }, { "@type": "Question", "name": "Comment évaluer l'impact des facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des études épidémiologiques et des données cliniques pour quantifier l'impact." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque modifiables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'alimentation, l'activité physique et la consommation d'alcool." } }, { "@type": "Question", "name": "Comment intégrer les facteurs de risque dans la prise de décision ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer les risques individuels et discuter des options de gestion avec le patient." } } ] } ] }

Sources (10000 au total)

Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.

This study investigated the demand for and awareness of a primary healthcare pilot project for people with disabilities; it also sought to identify relevant determinants for demand and awareness using... This study is a secondary analysis of data from the population-based survey conducted in Gyeonggi Regional Health & Medical Center for People with Disabilities. The data was designed with quota ra... Awareness of the service (12.1%) was remarkably low, while the demand (80.5%) was high. The gap between respondents who needed the service but were unaware of it differed according to age, education, ... Chronic disease and an unmet need for medical care were key determinants of service demand, while the severity of disability was not. Thus, there is a need to review the initiative that defines servic...

[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].

Communication and interprofessional collaboration with patients diagnosed with cancer is challenging. Structured communication training has not yet been integrated into postgraduate medical education.... A needs assessment was conducted using focus groups and individual interviews. Learning objectives were aligned with (inter)national learning objective catalogs. The ICT was developed using the six-st... Physician participation rates in the workshops were 83.0% and nursing participation rates were 58.3%. Utilization of the workplace-based training was 97%. The physicians evaluated the ICT very positiv... The implementation of an ICT with 80 teaching units is successfully feasible in a urological clinic and leads to a sustainable improvement of the communication culture, among other things through ment...

[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].

Analysis of psychiatric-psychotherapeutic crisis services in the Leipzig Psychiatry Network (LeiP#netz), assigning the services to the functional areas of the FBM according to Steinhart and Wienberg.... A standardized survey of crisis care was conducted using the functions "complex outpatient treatment", "access to acute psychotherapy in crisis", and "24 h complex, intensive treatment" by means of fa... A total of 31 measures were recorded for the three functions. All crisis care services were highly utilized; in up to one-third of cases, no services could be provided when demand was requested. Servi... Crisis care services for severely mentally ill people are available in various constellations in the study region. Low-threshold 24/7 crisis services need to be expanded....

Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.

Social determinants of health (SDOH) and stress during pregnancy may contribute to adverse pregnancy outcomes. The objective of this in the field pilot project was to develop a comprehensive screening... Pregnant patients accessing prenatal care at a single site of an urban Federally Qualified Health Center were recruited during prenatal visits to complete a Social Determinants of Health in Pregnancy ... Between April 2018 and March 2019, 135 pregnant participants completed SIPT. Ninety-one percent of patients scored positive on at least one screener, 54% to three or more screeners.... Despite guidelines to screen for SDOH during pregnancy there is no universal tool. Our pilot project demonstrated the concurrent use of adapted screening tools where participants reported at least one...

Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.

Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative feca... In this feasibility study, 7039 individuals aged 50-75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHW... Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested posi... Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healt...

Conducting two evidence syntheses in six weeks - experiences with and evaluation of a pilot project.

Evidence synthesis organisations are trying to meet commissioners' needs for rapid responses to their evidence synthesis commissions. In this project we piloted an intensive process, working to comple... In a pre-planning phase, an intensive work group was established, and two commissions were selected for this pilot project. The evidence synthesis process was divided into two phases: planning and int... During the planning phase, teams identified significant uncertainties regarding scopes, research questions, and inclusion criteria. To address this, they engaged with commissioners earlier than origin... Overall, the intensive process fostered focus and productivity, allowing teams to manage short-term deliverables effectively. The researchers preferred working intensively with one evidence synthesis ...

[Implementation of a Pilot Project Supporting Parents Suffering from Cancer with Underage Children].

Families with one parent suffering from cancer are exposed to extraordinary emotional and organizational burdens, affecting underaged children. To help coordinated access to social and logistic suppor... A cross-sectional observational study was conducted using a mixed-method approach. Semi-structured written expert surveys (n=10) and secondary analysis of routine data of the care model (n=171 familie... Quantitative secondary analysis: The participating families had 1-7 children (median (m) 2, range (s) 6). In 66% of the cases, the mother was affected by cancer, in 20% the diseased parent was in a si... The data collected indicate that in families, matching the German average in their socio-demographic characteristics, a great need for organizational support develops as soon as one parent becomes sic...

A pilot project of expert nurses for the follow-up of complex intravenous antimicrobial treatment.

To report a pilot project of expert nurses for outpatient parenteral antimicrobial treatment (OPAT) follow-up.... Three nurses with specific training on antibiotics started a state-funded programme including: i) consultations for OPAT follow-up; ii) hotline for satellite hospitals; iii) peer training. Patients' d... From December 2020 to December 2021, 118 patients (median age 66.5 years [52-75], male-to-female ratio 2.5) were enrolled, for a total of 621 consultations. Patients were mostly on OPAT for bone and j... Nurses may be important actors for OPAT follow-up....

Implementation of entrustable professional activities into fellowship council accredited programs: a pilot project.

The Fellowship Council (FC) is transitioning to a competency-based medical education (CBME) model, including the introduction of Entrustable Professional Activities (EPAs) for training and assessment ... The FC coordinated the development of EPAs in collaboration with the sponsoring societies for Advanced GI/MIS, Bariatrics, Foregut, Endoscopy and Hepatopancreaticobiliary (HPB) fellowships encompassin... The 15 participating programs included 18 fellows and 106 faculty. A total of 655 assessments were initiated with 429 (65%) completed. The average (SD) number of EPAs completed for each fellow was 24(... A competency-based assessment framework was developed by the FC and piloted in several programs. Participation was variable and required ongoing strategies to address barriers. The pilot project has p...